Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Change in Receivables (2017 - 2025)

cbdMD's Change in Receivables history spans 10 years, with the latest figure at $76755.0 for Q4 2025.

  • For Q4 2025, Change in Receivables fell 73.44% year-over-year to $76755.0; the TTM value through Dec 2025 reached $227384.0, up 27.57%, while the annual FY2025 figure was $439565.0, 347.14% up from the prior year.
  • Change in Receivables for Q4 2025 was $76755.0 at cbdMD, down from $456916.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.0 million in Q1 2021 and bottomed at -$815369.0 in Q2 2022.
  • The 5-year median for Change in Receivables is -$27183.5 (2021), against an average of $14412.3.
  • The largest annual shift saw Change in Receivables surged 13544.47% in 2021 before it crashed 11957.77% in 2022.
  • A 5-year view of Change in Receivables shows it stood at -$4554.0 in 2021, then plummeted by 11957.77% to -$549111.0 in 2022, then soared by 87.77% to -$67169.0 in 2023, then skyrocketed by 530.16% to $288936.0 in 2024, then tumbled by 73.44% to $76755.0 in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Change in Receivables are $76755.0 (Q4 2025), $456916.0 (Q3 2025), and -$84759.0 (Q2 2025).